SWEDISH MEDICAL CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1910-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.swedish.org/
Early Chest Tube Removal After Surgery for Primary Spontaneous Pneumothorax: A Randomized Controlled Trial
Not Applicable
Recruiting
- Conditions
- Primary Spontaneous Pneumothorax
- Interventions
- Procedure: Early Chest Tube RemovalProcedure: Standard Chest Tube RemovalDevice: Apical Chest Tube
- First Posted Date
- 2024-05-13
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Swedish Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT06411431
- Locations
- 🇺🇸
Swedish Cancer Institute, Seattle, Washington, United States
Minimally Invasive Esophagectomy Pain Control Trial
Phase 1
Recruiting
- Conditions
- Postoperative ComplicationsPostoperative Pain, Acute
- Interventions
- Procedure: Thoracic epidural catheterProcedure: Local intercostal nerve blockProcedure: Cryo-analgesia and intercostal nerve blockProcedure: Serratus plane catheter blocks and intercostal nerve blocks
- First Posted Date
- 2023-06-15
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Swedish Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT05906134
- Locations
- 🇺🇸
Swedish Cancer Institute, Seattle, Washington, United States
Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma
Early Phase 1
Recruiting
- Conditions
- Newly Diagnosed Glioblastoma
- Interventions
- Drug: combinations of up to 3 FDA approved drugs from a panel of compounds
- First Posted Date
- 2022-05-18
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Swedish Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT05380349
- Locations
- 🇺🇸
Swedish Medical Center, Seattle, Washington, United States
Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy
Phase 2
Terminated
- Conditions
- Covid19SARS-CoV Infection
- Interventions
- Dietary Supplement: Zinc Picolinate PlaceboDietary Supplement: Zinc PicolinateDietary Supplement: Resveratrol PlaceboDietary Supplement: Resveratrol
- First Posted Date
- 2020-09-09
- Last Posted Date
- 2022-07-29
- Lead Sponsor
- Swedish Medical Center
- Target Recruit Count
- 45
- Registration Number
- NCT04542993
- Locations
- 🇺🇸
Swedish Medical Center, Seattle, Washington, United States
Rectal Versus Oral Diazepam Administration in the Treatment of Levator Ani Syndrome
- First Posted Date
- 2020-01-03
- Last Posted Date
- 2023-04-19
- Lead Sponsor
- Swedish Medical Center
- Registration Number
- NCT04216797
- Locations
- 🇺🇸
Swedish Medical Center Colon Rectal Clinic, Seattle, Washington, United States
Management of Pleural Space Infections
Phase 4
Completed
- Conditions
- Empyema, PleuralParapneumonic Effusion
- Interventions
- Drug: Intrapleural MedicationsProcedure: SurgeryProcedure: Pleural SamplingProcedure: Pleural fluid drainageRadiation: Protocol Image #1Other: Surgical ConsultationBehavioral: Quality of Life
- First Posted Date
- 2019-03-13
- Last Posted Date
- 2022-11-22
- Lead Sponsor
- Swedish Medical Center
- Target Recruit Count
- 26
- Registration Number
- NCT03873766
- Locations
- 🇺🇸
Swedish Cancer Institute, Seattle, Washington, United States
Acalabrutinib Plus RICE for Relapsed/Refractory DLBCL
Phase 2
- Conditions
- Diffuse Large B Cell Lymphoma
- Interventions
- Biological: RituximabOther: Autologous HSCT
- First Posted Date
- 2018-11-09
- Last Posted Date
- 2022-07-22
- Lead Sponsor
- Swedish Medical Center
- Target Recruit Count
- 47
- Registration Number
- NCT03736616
- Locations
- 🇺🇸
Swedish Cancer Institute, Seattle, Washington, United States
A Trial Comparing Single Agent Melphalan to Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) as a Preparative Regimen for Patients With Multiple Myeloma Undergoing High Dose Therapy Followed by Autologous Stem Cell Reinfusion
Phase 2
Recruiting
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2018-06-27
- Last Posted Date
- 2022-06-22
- Lead Sponsor
- Swedish Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT03570983
- Locations
- 🇺🇸
Swedish Cancer Institute, Seattle, Washington, United States
Unobtrusive Sensing of Medication Intake ("USE-MI")
Not Applicable
Recruiting
- Conditions
- Medication Adherence
- Interventions
- Behavioral: USE-MI System
- First Posted Date
- 2018-06-27
- Last Posted Date
- 2022-04-28
- Lead Sponsor
- Swedish Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT03571022
- Locations
- 🇺🇸
Swedish Medical Center, Seattle, Washington, United States
A Trial Comparing Transversus Abdominis Plane Catheter Versus Epidural After Esophagectomy
Not Applicable
Terminated
- Conditions
- Esophageal CancerPain, Postoperative
- Interventions
- Procedure: EsophagectomyProcedure: Transversus abdominis plane catheterProcedure: Epidural
- First Posted Date
- 2018-06-27
- Last Posted Date
- 2023-01-23
- Lead Sponsor
- Swedish Medical Center
- Target Recruit Count
- 38
- Registration Number
- NCT03570996
- Locations
- 🇺🇸
Swedish Cancer Institute, Seattle, Washington, United States
© Copyright 2025. All Rights Reserved by MedPath